Apervita
Chicago, US · Founded 2012 · Delaware corporation · 5 known investors
Find your way into Apervita
An online store selling injectable and oral anabolic steroids, HGH, and post-cycle therapy products directly to consumers.
Founders & leadership
Apervita was founded in 2012 by Paul Magelli and Geoff Phillips.
PM
Paul MagelliCo-founder
GP
Geoff PhillipsinCo-founder
BM
Blackford MiddletonExecutive
AS
Aaron SymanskiExecutive
ML
MO
Michael OltmanNamed on SEC filing
NL
Noah LewisNamed on SEC filing
BR
Brad RyanNamed on SEC filing
DS
David ShreinerNamed on SEC filing
DT
David TuttleNamed on SEC filing
Board
Investors · 5
Reported raises · per SEC filings
Form D private placements$22.6M disclosed across 1 of 3 rounds · 2014–2019
▶$22.6MraisedOct 2019 · 17 investors · Other Health CareRule 506(b)
▶$22.6MraisedOct 2019 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James BradleyDirector
- Kevin HutchinsonExecutive Officer, Director
- Mark AchlerDirector
- Adam KoopersmithDirector
- Michael LiangDirector
- Kevin WeinsteinExecutive Officer
- Kenneth JakobsenExecutive Officer
- Blackford MiddletonExecutive Officer
- Michael OltmanExecutive Officer
- William McNallyExecutive Officer
- Sarah LondonDirector
- Offering amount
- $22.6M
- Amount sold
- $22.6M
- Minimum investment
- $26.5K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.5MofferedAug 2017 · Other Health CareRule 506(b)
▶$16.5MofferedAug 2017 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael LiangDirector
- Blackford MiddletonExecutive Officer
- Michael OltmanExecutive Officer
- Noah LewisDirector
- Paul MagelliExecutive Officer, Director
- Brad RyanExecutive Officer
- David ShreinerExecutive Officer
- David TuttleExecutive Officer
- Offering amount
- $16.5M
- Minimum investment
- $15K
- Finders' fees
- $520K
- Placement agents
- Manor Park Securities LLC
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$26MofferedDec 2014 · Other Health CareRule 506(b)
▶$26MofferedDec 2014 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark AchlerDirector
- Geoff PhillipsExecutive Officer, Director, Promoter
- Paul J MagelliExecutive Officer, Director, Promoter
- Aaron SymanskiExecutive Officer
- Offering amount
- $26M
- Minimum investment
- $25K
- Proceeds to insiders
- $300B
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Revvity13 shared keywordsRevvity develops and sells reagents, instruments, software, and services for life sciences research and clinical diagnostics, serving pharmaceutical, biotech, academic and government institutions across drug discovery, development, and disease diagnosis workflows.
Enhanced12 shared keywordsEnhanced develops a scientific platform that combines sports performance analysis with human potential optimization. The company serves athletes and individuals seeking evidence-based approaches to safely enhance performance.
Companies competing with Apervita for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Apervita do?
- An online store selling injectable and oral anabolic steroids, HGH, and post-cycle therapy products directly to consumers.
- Who founded Apervita?
- Apervita was founded by Paul Magelli, Geoff Phillips in 2012.
- Who are Apervita's investors?
- Apervita's investors include Bootstrap Venture Partners, Baird Capital, Graphene Ventures, Optum Ventures, Pritzker Group Venture Capital.
- How much funding has Apervita raised?
- Apervita has disclosed $22.6M raised across 1 of its 3 known rounds.
- Where is Apervita headquartered?
- Apervita is headquartered in Chicago, US.